FDA Inspection 1216222 — RCHP Billings-Missoula, LLC.
The FDA completed an inspection of RCHP Billings-Missoula, LLC. on Aug 1, 2023 in Missoula, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Missoula, MT (United States)